Clinical Trial: Beclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthma

U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07768891) titled 'Beclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthma' on July 21.

Brief Summary: A multicenter, randomized, double-blind, active-controlled, parallel-group Phase III clinical study comparing the efficacy and safety of Beclometasone Dipropionate and Formoterol Inhalation Aerosol versus FOSTER(R) in patients with asthma. The purpose of this study is to compare the efficacy and safety of the Beclomethasone Dipropionate and Formoterol Fumarate inhalation aerosol (manufactured by Lunan Better Pharmaceutical Co., Ltd.) with FOSTER(R) in the treatment of patients with asthma.

Study Start Date: June 08

Study Type: INTER...